Skip to search formSkip to main contentSkip to account menu

Latent Autoimmune Diabetes in Adults

Known as: Latent Autoimmune Diabetes of Adults, Latent Autoimmune Diabetes in Adults [Disease/Finding], Type 1.5 Diabetes 
Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC… 
National Institutes of Health

Related topics

Related topics

6 relations
In BloodMicrobiologicalchemically inducednursing therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
OBJECTIVE Latent autoimmune diabetes in adults (LADA) shares clinical features with both type 1 and type 2 diabetes; however… 
Review
2018
Review
2018
Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management
Latent autoimmune diabetes in adults (LADA) is a heterogeneous disease characterized by a less intensive autoimmune process and a… 
2018
2018
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
Purpose Bone formation is impaired in both type 1 diabetes and type 2 diabetes (T2D), whereas sclerostin, an antagonist of bone… 
Highly Cited
2014
Highly Cited
2014
Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
CONTEXT Dipeptidyl peptidase 4 (DPP-4) inhibitors have been widely used in type 2 diabetes. An important unanswered question… 
Highly Cited
2011
Highly Cited
2011
Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4
Aims/hypothesisSystemic pro- and anti-inflammatory cytokines are associated with both type 1 and type 2 diabetes, while their… 
Review
2010
Review
2010
Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity.
Latent autoimmune diabetes in adults (LADA) accounts for 2%-12% of all cases of diabetes. Patients are typically diagnosed after… 
Highly Cited
2010
Highly Cited
2010
Latent Autoimmune Diabetes in Adults Differs Genetically From Classical Type 1 Diabetes Diagnosed After the Age of 35 Years
OBJECTIVE We studied differences between patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes, and… 
Highly Cited
2009
Highly Cited
2009
Protective effects of 1‐α‐hydroxyvitamin D3 on residual β‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA)
Previous in vitro and in vivo studies have demonstrated that vitamin D could prevent pancreatic β‐cell destruction and reduce the… 
Highly Cited
2005
Highly Cited
2005
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.
Highly Cited
2002
Highly Cited
2002
Latent Autoimmune Diabetes in Adults
Abstract: Latent autoimmune diabetes in adults (LADA) is a special form of diabetes that is clinically similar to type 2 diabetes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)